These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31306598)

  • 1. Effect of Clear Speech on the Duration of Silent Intervals at Syntactic and Phonemic Boundaries in the Speech of Individuals With Parkinson Disease.
    Gravelin AC; Whitfield JA
    Am J Speech Lang Pathol; 2019 Jul; 28(2S):793-806. PubMed ID: 31306598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the distribution of silent intervals in the connected speech of individuals with Parkinson disease.
    Whitfield JA; Gravelin AC
    J Commun Disord; 2019; 78():18-32. PubMed ID: 30612045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intelligibility Across a Reading Passage: The Effect of Dysarthria and Cued Speaking Styles.
    van Brenk F; Stipancic K; Kain A; Tjaden K
    Am J Speech Lang Pathol; 2022 Jan; 31(1):390-408. PubMed ID: 34982941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear Speech Variants: An Investigation of Intelligibility and Speaker Effort in Speakers With Parkinson's Disease.
    Stipancic KL; van Brenk F; Kain A; Wilding G; Tjaden K
    Am J Speech Lang Pathol; 2022 Nov; 31(6):2789-2805. PubMed ID: 36327495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of Clear Speech in Parkinson Disease Using Measures of Working Vowel Space.
    Whitfield JA; Mehta DD
    J Speech Lang Hear Res; 2019 Jul; 62(7):2082-2098. PubMed ID: 31306606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptual measures of speech from individuals with Parkinson's disease and multiple sclerosis: intelligibility and beyond.
    Sussman JE; Tjaden K
    J Speech Lang Hear Res; 2012 Aug; 55(4):1208-19. PubMed ID: 22232396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentence-Level Movements in Parkinson's Disease: Loud, Clear, and Slow Speech.
    Kearney E; Giles R; Haworth B; Faloutsos P; Baljko M; Yunusova Y
    J Speech Lang Hear Res; 2017 Dec; 60(12):3426-3440. PubMed ID: 29209727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Acoustic Speech Temporal Characteristics for Mandarin Speakers With Parkinson's Disease During Syllable Repetition and Passage Reading.
    He D; Feenaughty L; Wan Q
    Am J Speech Lang Pathol; 2023 Sep; 32(5):2232-2244. PubMed ID: 37625136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions.
    Tjaden K; Lam J; Wilding G
    J Speech Lang Hear Res; 2013 Oct; 56(5):1485-502. PubMed ID: 23838989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria.
    Hammen VL; Yorkston KM
    J Commun Disord; 1996; 29(6):429-44; quiz 444-5. PubMed ID: 8956101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease.
    Goberman AM; Elmer LW
    J Commun Disord; 2005; 38(3):215-30. PubMed ID: 15748725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classifications of vocalic segments from articulatory kinematics: healthy controls and speakers with dysarthria.
    Yunusova Y; Weismer GG; Lindstrom MJ
    J Speech Lang Hear Res; 2011 Oct; 54(5):1302-11. PubMed ID: 21646421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybridizing conversational and clear speech to investigate the source of increased intelligibility in speakers with Parkinson's disease.
    Tjaden K; Kain A; Lam J
    J Speech Lang Hear Res; 2014 Aug; 57(4):1191-205. PubMed ID: 24686409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clear speech on acoustic measures of dysprosody in Parkinson disease for different reading tasks.
    Coy AG; Whitfield JA
    Int J Speech Lang Pathol; 2023 Sep; ():1-14. PubMed ID: 37668056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Articulatory-acoustic vowel space: application to clear speech in individuals with Parkinson's disease.
    Whitfield JA; Goberman AM
    J Commun Disord; 2014; 51():19-28. PubMed ID: 25074511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voicing contrast of stop consonant production in the speech of individuals with Parkinson disease ON and OFF dopaminergic medication.
    Whitfield JA; Reif A; Goberman AM
    Clin Linguist Phon; 2018; 32(7):587-594. PubMed ID: 29064294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.